EV/EBITDA
-2.43
-0.05-2.10%
Thu, 28 Nov 2024 00:56:32 GMT
Summary:
Adaptimmune Therapeutics EV/EBITDA is currently -2.43, with a fall of -0.05 (-2.10%) during the most recent trading day. Over the past year, it has dropped by -2.07 (-575.00%). ADAP EV/EBITDA is now -710.00% below its all-time high of -0.30.ADAP EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADAP EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | -2.1% |
| 3 m3 months | -5.2% |
| 6 m6 months | -200.0% |
| ytdytd | -417.0% |
| 1 y1 year | -575.0% |
| 5 y5 years | -279.7% |
ADAP EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -1.95 | -24.6% | -2.43 | at low |
| 3 m | 3 months | -1.16 | -109.5% | -2.59 | +6.2% |
| 6 m | 6 months | -0.53 | -358.5% | -3.11 | +21.9% |
| 1 y | 1 year | -0.33 | -636.4% | -3.11 | +21.9% |
| 3 y | 3 years | -0.30 | -710.0% | -4.21 | +42.3% |
| 5 y | 5 years | -0.30 | -710.0% | -13.19 | +81.6% |
| alltime | all time | -0.30 | -710.0% | -257.80 | +99.1% |
Adaptimmune Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -2.43(+417.0%) |
| 2023 | -0.47(-52.0%) |
| 2022 | -0.98(-66.9%) |
| 2021 | -2.96(-53.5%) |
| 2020 | -6.37(+727.3%) |
| Date | Value |
|---|---|
| 2019 | -0.77(-89.2%) |
| 2018 | -7.12(-1.1%) |
| 2017 | -7.20(+297.8%) |
| 2016 | -1.81(-96.8%) |
| 2015 | -56.20 |
FAQ
- What is Adaptimmune Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Adaptimmune Therapeutics?
- What is ADAP EV/EBITDA year-to-date change?
- What is Adaptimmune Therapeutics EV/EBITDA year-on-year change?
What is Adaptimmune Therapeutics EV/EBITDA?
The current EV/EBITDA of ADAP is -2.43
What is the all time high EV/EBITDA for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high EV/EBITDA is -0.30
What is ADAP EV/EBITDA year-to-date change?
Adaptimmune Therapeutics EV/EBITDA has changed by -1.96 (-417.02%) since the beginning of the year
What is Adaptimmune Therapeutics EV/EBITDA year-on-year change?
Over the past year, ADAP EV/EBITDA has changed by -2.07 (-575.00%)